triiodothyronine has been researched along with Heart Septal Defects, Ventricular in 3 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Infants less than 1 year old undergoing ventricular septal defect or tetralogy of Fallot repair were randomized into 2 groups." | 2.69 | Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease. ( Duncan, BW; Fearneyhough, C; Lupinetti, FM; Ning, XH; Portman, MA; Rosenthal, GL, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danzi, S | 1 |
| Klein, I | 1 |
| Portman, MA | 2 |
| Mackie, AS | 1 |
| Booth, KL | 1 |
| Newburger, JW | 1 |
| Gauvreau, K | 1 |
| Huang, SA | 1 |
| Laussen, PC | 1 |
| DiNardo, JA | 1 |
| del Nido, PJ | 1 |
| Mayer, JE | 1 |
| Jonas, RA | 1 |
| McGrath, E | 1 |
| Elder, J | 1 |
| Roth, SJ | 1 |
| Fearneyhough, C | 1 |
| Ning, XH | 1 |
| Duncan, BW | 1 |
| Rosenthal, GL | 1 |
| Lupinetti, FM | 1 |
3 trials available for triiodothyronine and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
Effect of triiodothyronine on gene transcription during cardiopulmonary bypass in infants with ventricular septal defect.
Topics: Adenine Nucleotide Translocator 1; Biopsy, Needle; Cardiopulmonary Bypass; Female; Heart Septal Defe | 2005 |
A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery.
Topics: Aorta, Thoracic; Cardiac Output; Cardiac Surgical Procedures; Double-Blind Method; Female; Heart Def | 2005 |
Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease.
Topics: Cardiopulmonary Bypass; Heart Defects, Congenital; Heart Septal Defects, Ventricular; Hemodynamics; | 2000 |